Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-01 Sale |
2021-02-03 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $48.15 | $180,563 | 81,648 (Direct) |
View |
| 2021-01-25 Sale |
2021-01-27 4:25 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $48.39 | $725,814 | 142,707 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $49.47 | $1,236,719 | 74,425 (Direct) |
View |
| 2020-12-28 Sale |
2020-12-30 4:15 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $51.45 | $1,286,157 | 99,425 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-01 Exercise |
2021-02-03 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $5.55 | 81,648 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 4:15 pm |
N/A 2027-10-02 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
3,750 | $0 | 81,648 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 4:25 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $0 | 142,707 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-27 4:25 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $0.41 | 142,707 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 4:15 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0 | 74,425 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-21 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0.41 | 74,425 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:15 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0 | 99,425 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-30 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
25,000 | $0.41 | 99,425 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-23 5:55 pm |
N/A 2030-06-21 |
BioXcel Therapeutics Inc. | BTAI | Benabou Reina See Remarks |
60,000 | $0 | 60,000 (Direct) |
View |